INTRODUCTION
Triple negative breast cancers, melanomas, glioblastomas, pancreatic cancers, ovarian, and nonsmall-cell lung cancers are some of the cancers associated with the worst outcomes thanks to their ability to resist most of the standard therapies. The health challenge represented by these cancers can only be met by innovative medical approaches that combine ground-breaking chemistry with novel biology and the latest tools of medical intervention.
All these cancers share the characteristics of intrinsic resistance to pro-apoptotic stimuli, which limits the eff ectiveness of the available chemotherapies. 1 In the search for new therapeutic strategies, a new medicinal chemistry based on the unique behavior of organometallic complexes of transition metals may provide a breakthrough. The approach is distinct from coordination chemistry [2] [3] [4] because it concerns organometallics with a direct metal-carbon covalent bond, often associated with a low degree of oxidation. The advent of organometallic frameworks designed with precise biological end points in mind was delayed for some time by organometallic chemists' primary focus on catalysis, which for some years had the eff ect of relegating other aspects of the field to obscurity. 5 This situation changed with the arrival of bioorganometallics. 6, 7 It is now clear that an innovative organometallic medicinal chemistry 8, 9 is supported by the distinctive properties of organometallic complexes, for example, the three-dimensional space-filling capability demonstrated by Do rr and Meggers for kinase and other enzyme inhibitors. 10 Alternatively, some organometallic complexes inhibit target proteins by metal coordination to their active site. [11] [12] [13] In this context, the potential interest of N-heterocyclic carbene (NHC)
complexes of Au(I) and Ru(II) as anticancer drugs has been evaluated. [14] [15] [16] [17] NHC ligands stabilize metal ions against precipitation into aggregates under physiological conditions and at the same time can serve to deliver bioactive metal ions to the cellular targets. These species have mechanisms of action diff erent from that of cisplatin 2 because redox proteins such as thioredoxin reductase (TrxR) can be considered as key targets.
Another strategy to overcome cancer cell resistance with new types of organometallic prodrugs is to use non-noble metals and generate active metabolites in the vicinity of redox targets. Among the usable organometallic complexes, the iron complexes occupy a privileged position owing to the abundance of this metal in the body and the particular nature of ferrocene, which is a compact and stable aromatic metallocene with redox properties and a bioisostere of benzene. 8 For example, substitution of a phenyl ring by a ferrocenyl unit in OHTAM, the active metabolite of tamoxifen, the drug classically used to treat hormone dependent breast cancer leads to FcOHTAM (Chart 1), which showed a strong cytotoxic eff ect on both estrogen receptor positive and negative breast cancer cell lines (MCF-7 and MDA-MB-231, respectively).
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Chart 1. Chemical Structures of the Ferrocenyl Derivatives under Study
Indeed an IC 50 of 0.5 μM was found for the lipophilic complexes 2, the corresponding diphenol analogue 3, and 1.1 μM for the ferrocenyl monophenol compound 1 on MDA-MB-231 cells. [21] [22] [23] Compound 3 and other ferrocifens were active against a large panel of cancer cell lines 24 but not on healthy cells (astrocytes, melanocytes). 25, 26 The eff ectiveness of 2 and 3 delivered via lipid nanocapsules (LNC) has been studied in vivo on 9L-glioma models 26, 27 and on xenografted MDA-MB-231 cells. 28 A significant slowing of tumor progression was observed, demonstrating the antiproliferative activity of these compounds in vivo.
1, 2, and 3 can undergo chemical oxidation to give the quinone methides (QM) as products of the initial oxidation of the Fe(II) of ferrocenyl to the Fe(III) of ferricinium. 29 Electrochemical experiments have provided elucidation of the oxidation pathway leading to the quinone methide, which occurs at biologically relevant potentials. 30 It has been speculated that the cytotoxicity of 1 and some other ferrociphenols may arise at least partly from the electrophilic character of the quinone methide metabolites. 31 Two major systems, namely the thioredoxin (Trx) and glutathione (GSH) systems, are involved in the control of cellular thiol redox balance. The first system depends on thioredoxin reductase (TrxR) which is reduced by NADPH and in turn maintains Trx in the reduced form. 32, 33 Among other functions, Trx acts as an electron donor for the family of peroxiredoxins that catalyze the reduction of H 2 O 2 to water. 34 TrxRs are large homodimeric flavoproteins, and two isoforms, a cytosolic (TrxR1) and a mitochondrial (TrxR2) form, have been identified. 35, 36 TrxRs possess an N-terminal redox center characterized by a dithiol motif (Cys-XXXX-Cys) and a C-terminal active site with a Cys-Sec motif (Sec = selenocysteine). The Sec residue is characterized by a low pK a (5.24 for the selenol/selenate couple compared to 8.25 for the thiol/thiolate couple), resulting in an enhanced nucleophilic character. 37, 38 Thioredoxin reductase is considered an attractive target for development of anticancer agents as it is frequently overexpressed in cancer cells. [39] [40] [41] Some metal complexes inhibit TrxR at the nanomolar to submicromolar level mostly by metal coordination, [42] [43] [44] while electrophilic organic compounds inhibit TrxR at the micro/submicromolar level. [45] [46] [47] [48] [49] [50] Both classes of inhibitors target TrxR via an (ir)reversible reaction with the Cys-Sec motif at the C-terminus.
The second system is based on glutathione, maintained in a reduced state by glutathione reductase (GR), which is in turn reduced by NADPH. 51, 52 Reduced glutathione acts as a substrate of glutathione peroxidase (GPx), another selenoenzyme able to decompose hydrogen peroxide to water, 53 thereby contributing, together with peroxiredoxins, to the maintenance of cell redox balance.
In the present study, the eff ect of 1 and 2 and their respective quinone methides (1-QM, 2-QM) on the activity of the isolated selenoenzymes TrxR and GPx and the homologous enzyme GR as well as the reactivity of the QMs on organic models was investigated and compared. The eff ects of these compounds on molecules involved in cellular redox homeostasis was further studied on Jurkat cancer cells in order to shed light on the molecular mechanism of action of these compounds that may be responsible for cancer cell growth inhibition. Eff ects of Ferrocenyl Compounds on Isolated Enzymes (TrxR1, TrxR2, GR, and GPx). The inhibitory eff ect of the ferrocenyl derivatives on the enzymatic activity of purified TrxR1 (cytosolic isoform of thioredoxin reductase) was tested using the DTNB reduction method. As can be seen in Figure 1A, Figure 1B ). This diff erence of inhibitory efficiency between the two isoforms of TrxR may be due to the diff erent properties of the mitochondrial and cytosolic enzymes (see Discussion).
RESULTS
Synthesis of Quinone Methides (QMs
The ferrocenyl derivatives were also tested as inhibitors of TrxR1 after their in situ oxidation with H 2 O 2 /HRP (horseradish peroxidase). As shown in Supporting Information, Figure Figure S1 ).
Glutathione reductase, like thioredoxin reductase, belongs to the family of pyridine nucleotide oxidoreductases but lacks the thiol/selenol motif at the C-terminus. Interestingly, this enzyme was scarcely aff ected by any of the four compounds ( Figure 1C ) and a slight inhibition for some of them was observed only at relatively high concentrations.
Like thioredoxin reductase, glutathione peroxidase is also a selenoenzyme containing a selenocysteine in each subunit. 53 This enzyme is directly concerned with the removal of hydrogen peroxide using reducing equivalents of GSH. The phenols (1, 2) and quinone methides (QM-1, QM-2) did not significantly alter the activity of glutathione peroxidase ( Figure 1D ). Similar selectivity for TrxR over GPx was previously observed in the case of alkylation-mediated inhibition by acylfulvenes. 48 Furthermore, to inhibit GPx, some gold complexes such as auranofin are required at relatively high concentrations in comparison to those needed for TrxR. 54 This inability of the quinone methides to inhibit GPx is probably linked to the fact that, unlike TrxR, the selenol active site is hidden within the enzyme core and consequently unable to interact with the bulky organometallic complexes.
Localization of the Ferrocenyl Compounds Inhibition Site on TrxR1
. To obtain information on the type of inhibition exerted on thioredoxin reductase by the ferrocenyl derivatives, a BIAM (biotin-conjugated iodoacetamide) assay was used. This assay makes it possible to evaluate the ability of the compounds to react with the thiol/selenol motif. In fact, BIAM can selectively alkylate TrxR depending on pH. At pH 6.0, only selenocysteine and low pK a cysteine can be alkylated, while at pH 8.5, both selenocysteine and cysteine can be derivatized by BIAM. As shown in Figure 2 , preincubation of 2-QM at 100 μM appeared to inhibit almost completely the conjugation of BIAM to TrxR1. Moreover, this inhibition occurred at both pH 6.0 and 8.5, suggesting that 2-QM selectively bound to the selenol moiety at the C-terminus of TrxR1. 1-QM showed a minor eff ect at pH 6.0 and 8.5. Furthermore, competitive reaction of equimolar amounts of reduced cystamine and selenocystamine with both QMs led only to the formation of the selenide adducts (not shown). On the basis of HPLC analysis, the amount of selenide adduct 4, formed from 2-QM, was larger than that formed from 1-QM. We interpret this finding as the highly favored competitive conversion of 1-QM to the indene derivative 5 in protic medium (Scheme 2). 57 The indene adduct in the 1-QM solution was identified as the major peak at t R = 31 min by comparative analysis of an authentic sample. Comparatively, 2-QM reproducibly appeared more stable in aqueous medium. Under these experimental conditions, 2 and 2-QM inhibited TrxR activity in a concentration-dependent fashion, with about 60% inhibition at 20 μM. Conversely, the other two compounds (1 and 1-QM) were scarcely eff ective. Glutathione reductase and peroxidase were essentially not inhibited by ferrocenyl compounds. Rather, in the case of glutathione reductase, there was an increase of activity above the control especially in the presence of quinone methides ( Figure 3B ). Therefore, the total amounts of glutathione and of oxidized glutathione in cells incubated with the ferrocenyl compounds at 10 or 20 μM were determined. As shown in Figure 4 , an increase of total glutathione was observed for the cells incubated with the quinone methides, except for the higher concentration of 2-QM.
The proportion of oxidized glutathione GSSG was also significantly increased in the presence of 2 and to a lesser extent in the presence of 1 (Figure 4) . Similarly, and consistently with the previous results, Trx2 was also markedly oxidized in the presence of both 2 and 2-QM, while a lower proportion of oxidized forms of Trx2 (but significantly higher than control) was observed for cells incubated with 1 and 1-QM ( Figure   5B ). Table 1 gives a full overview of the main biochemical results obtained with the ferrocenyl compounds on isolated enzymes and Jurkat cells.
Estimation of the
DISCUSSION
Because quinone methides are reactive species with well-established electrophilicity, it was hypothesized that they could behave as inhibitors of TrxR. Indeed, both QMs under study exhibited an IC 50 around 2 μM for the cytosolic form of TrxR while their phenol precursors were much less active on both TrxR1 and TrxR2. Subtle diff erences between 2-QM and 1-QM were observed on TrxR2, as the former was only half as active as the latter. Even though TrxR1 and TrxR2 share common structural features, they have recently been shown to display subtle diff erences in substrate selectivity and inhibition by gold compounds. 60 Other diff erences might be taken into account to explain the selectivity of 2-QM toward TrxR1 such as the more basic character of TrxR2 with respect to TrxR1 61 and the much higher sensitivity of TrxR1 to calcium ion inhibition with respect to TrxR2. 62 Further experiments using the BIAM assay suggested that the selenol group of Sec498 was the target of both QMs. Accordingly, the structurally related enzyme glutathione reductase, which contains two Cys residues instead of the C-terminal Cys-Sec motif, was not aff ected by any of the ferrocenyl compounds. The other important selenoenzyme glutathione peroxidase was also not aff ected by any of the ferrocenyl compounds, indicating that an accessible selenocysteine residue was required for reaction with the QMs.
Model reactions carried out between both QMs and reduced cystamine and selenocystamine confirmed that selective alkylation of selenol occurred at neutral pH as evidenced by ESI-MS analyses. In contrast, the QMs derived from OHTAM and metabolite E (which is the phenyl analogue of 1) undergo fast reaction with GSH at physiological pH (half-life of 4 min). 55, 56 This discrepancy is attributable to the lower electrophilic character of the ferrocenyl quinone methides because of the delocalization of positive charge onto the ferrocenyl substituent, which leads to marked selectivity between thiols and selenols. Similarly to the isolated enzymes, the activity of glutathione reductase and peroxidase in cell lysates was not altered. On the contrary, stimulation of glutathione reductase activity was observed, particularly with 1-QM. Therefore, the eff ect of the ferrocenyl compounds on the glutathione level and its redox state was examined. It was found that together with GR, the total glutathione content increased, especially upon incubation with the QMs. The increased expression of GR and GSH points to the fact that QMs might stimulate some signaling pathways such as the Keap1-Nrf2 system involved in the regulation of expression of cytoprotective genes. This pathway is well-known to be induced by ROS and electrophiles of both natural and synthetic origins, including Michael acceptors, in a process leading to the expression of genes encoding a broad range of antioxidant enzymes such as peroxidases and enzymes involved in glutathione synthesis. 63 Compared to the control, the relative proportion of oxidized glutathione was five and three times higher in cells incubated with 2 and 1, respectively. Because no inhibition of glutathione reductase was simultaneously observed, the high level of GSSG most probably resulted from oxidative stress. This is in full agreement with the high level of ROS detected in MDA-MB-231 breast cancer cells upon incubation of 2 and 1 (Supporting Information, Figure S10 ). 64, 65 On the other hand, accumulation of oxidized forms of cytosolic and mitochondrial thioredoxins upon incubation with both 2 and its QM correlated well with the inhibition of cellular TrxR by both molecules. According to Du et al., these oxidized forms might be active in redox signaling. 59 These results again corroborate the fact that 2 is able to enter cells and undergoes oxidation to the QM form which appears as the active molecule able to inhibit TrxR and restrict the electron flow toward Trx, therefore stimulating its oxidation. Hence the putative mechanism of action of 2 that also rationalizes its cytotoxicity, appears to originate from its intracellular oxidation to the QM. This metabolite acts as an inhibitor of thioredoxin reductase, resulting in the accumulation of oxidized forms of thioredoxin which may in turn transmit its oxidized conditions to various cellular targets. Compound 1 and its QM appeared to behave diff erently in that they had scarcely any eff ect on the redox state of Trx1, which again correlates with the previous finding that neither 1 nor 1-QM significantly inhibited
TrxR in Jurkat cells (see above). However, 1 and its QM induced some oxidation of the mitochondrial form of Trx. This selectivity of 1 toward Trx2 may arise from the higher sensitivity of Trx2 to oxidative stress. 66 On the whole, the two ferrocifens under study displayed a similar behavior on isolated enzymes but not in cancer cells.
CONCLUSION
In conclusion, several pieces of biochemical evidence suggesting that the cytotoxicity of 2 originates from its intracellular conversion to an electrophilic quinone methide derivative, first hypothesized in 2006, 67 are provided herein for the first time. Thanks to the presence of the ferrocenyl substituent on 2, the QM was sufficiently stable to enable selective alkylation of TrxR both as isolated enzyme and in Jurkat cells. This study also underscored that 1 behaved diff erently owing to the very short lifetime of its QM in physiological medium that precluded TrxR inhibition in cancer cells. Nevertheless, this study substantiates the unique role of the ferrocenyl entity in the anticancer activity of both 1 and 2 and shows that activation, at least in part, goes through an intracellular oxidation pathway.
EXPERIMENTAL SECTION
Synthesis. 1 and 2 were synthesized according to the literature. 22, 68 Other chemicals were purchased from various manufacturers and used as received.
General Remarks. All reactions and manipulations were carried out under an argon atmosphere using standard Schlenk techniques. Acetonitrile was distilled over P 2 O 5 , acetone was dried over CaCl 2 , diethyl ether was distilled over sodium/benzophenone, and pentane was dried over 4 Å molecular sieves prior to use. Ag 2 O was prepared according to the literature procedure. 69 1 H and 13 C NMR spectra were acquired on a Bruker 300 MHz spectrometer. Mass spectrometry was carried out at the "Service de Spectrometrie de Masse"
at ENSCP, Paris. Microanalyses were performed by the "Service de Microanalyse ICSN" at Gif sur Yvette, France. Elemental analysis and NMR were used to determine the purity of the compounds, and the purity of 1-QM and 2-QM was found to be higher than 96%. Supporting Information, Figure S14 ): Glutathione reductase activity was measured at 25 °C on 80 μg protein/mL as reported above. Glutathione peroxidase activity was determined in 400 μg protein/mL of lysate in a final volume of 0.25 mL of 0.2 M Tris-HCl buff er (pH 8.1) and 1 mM EDTA as described above.
complete medium were incubated for 24 h with refresh at 12 h. Then cells were collected, washed twice with cold PBS, and then lysed and deproteinized with 6% meta-phosphoric acid.
After 10 min at 4 °C, samples were centrifuged and supernatants were neutralized with 15% Na 3 PO 4 and assayed for total glutathione. 74 Sample aliquots were derivatized with 2- mM IAM were added to the various samples, followed by incubation for 15 min at 37 °C.
Protein concentration was determined by the Lowry assay. 76 Proteins were separated by urea-
